Insiders have been trading these 5 stocks: ((STX)), ((SCHW)), ((ZOMDF)), ((KTOS)) and ((ALAB)). Here is a breakdown of their recent trades and their value.
Meet Samuel – Your Personal Investing Prophet
Explore STXX for 2X leverage on STXDirector William Mosley has turned heads at Seagate Tech by unloading 29,880 shares in a single move, a sale valued at a hefty $22,449,371, raising questions about his outlook on the company’s near-term prospects. Investors will be dissecting whether this insider sale signals simple profit-taking after gains or a more cautious stance on Seagate’s future performance.
At Charles Schwab, significant shareholder Charles Schwab himself executed two sizable stock sales, each involving 27,500 shares, signaling a major reshuffle of his personal stake. The transactions, worth $2,536,050 and $2,541,000 respectively, may prompt traders to reassess sentiment on Charles Schwab stock as they parse the timing and size of these insider moves.
Zomedica is bucking the insider-selling trend, as Director Johnny Powers stepped in to buy 200,000 shares of Zomedica stock in a purchase worth $20,000, suggesting confidence at the board level. Reinforcing this bullish tone, Sr. Vice President, Sales Klass Russell Kevin acquired 216,899 additional Zomedica shares for $21,689, a tandem vote of confidence that speculative investors will closely watch.
Defense name Kratos Defense saw more traditional insider selling when Director Boyd Bradley L disposed of 3,000 shares, locking in proceeds of $156,240 in the latest transaction. While modest in size compared with some peers, the sale will still enter the ledger for those who track insider signals as they gauge whether Kratos Defense can sustain its recent momentum.
Astera Labs, Inc. delivered the most dramatic insider action, with President & COO Sanjay Gajendra selling 95,444 shares for a striking $21,476,492, matched by CEO Jitendra Mohan unloading an identical 95,444 shares for another $21,476,492. Capping the wave, GC & Secretary Philip Mazzara sold 14,076 Astera Labs, Inc. shares worth $3,262,519, a trio of transactions that may fuel intense debate over how insiders view Astera’s valuation.